Lexicon Pharmaceuticals Inc. (LXRX) Live Share Price, Invest From India

Lexicon Pharmaceuticals Inc. Stock Performance

as on July 7, 2026 at 2:16 pm IST

Day's Low
Day's High
$2.30
Day's Price Range
$2.42
$2.32
0.86%
Downside
4.31%
Upside
52 Week's Low
52 Week's High
$0.84
52-Week Price Range
$2.68
$2.32
63.95%
Downside
15.52%
Upside

Lexicon Pharmaceuticals Inc. share price movements today

Previous Close: $2.32
Open: $2.33
Volume: 2.3M
Day's Low - High: $2.30 - $2.42
52 Week Low - High: $0.84 - $2.68

Lexicon Pharmaceuticals Inc. Historical Returns

1 Month Return: + 21.47 %
3 Month Return: + 45 %
1 Year Return: + 165.81 %
3 Year Return: + 4.5 %
5 Year Return: -40.36 %

Lexicon Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Lexicon Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-0.1587

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

PEG Ratio

-0.14

EBITDA

-23.7M

Revenue (TTM)

69.6M

Profit Margin

-37.46%

Return On Equity TTM

-16.01%

Lexicon Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexicon Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lexicon Pharmaceuticals Inc.	BUY	$1.0B	-40.36%	NA	-37.46%	NA
Revolution Medicines Inc.	BUY	$40.2B	512.87%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$41.8B	81.38%	78.79	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$134.0B	166.14%	31.36	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$68.6B	10.91%	15.97	29.65%	0.5700000000000001%

Stock Returns calculator for Lexicon Pharmaceuticals Inc. Stock including INR - Dollar returns

The Lexicon Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Lexicon Pharmaceuticals Inc. investment value today

Current value as on today

₹2,96,626

Returns

₹1,96,626

(+196.63%)

Returns from Lexicon Pharmaceuticals Inc. Stock

₹1,66,667 (+166.67%)

Dollar Impact

₹29,960 (+29.96%)

Analyst Recommendation on Lexicon Pharmaceuticals Inc. Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Lexicon Pharmaceuticals Inc.. Average target price of $3.77

Lexicon Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Lexicon Pharmaceuticals Inc..

What analysts predicted

38.46%UPSIDE

Target Price

$3.77

Current Price

$2.32

Analyzed by

11 Analysts

Target

$3.77

Lexicon Pharmaceuticals Inc. target price $3.77, a slight upside of 38.46% compared to current price of $2.32. According to 11 analysts rating.

Indian Investors' Interest in Lexicon Pharmaceuticals Inc. Stock

Search interest for Lexicon Pharmaceuticals Inc. Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 7, 2026 to July 7, 2026

Change:-47% versus previous 30 day period

Lexicon Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	1	1	1	26	1	28	14	5	21
Gross Profit	-14	0	1	1	0	1	28	14	5	20
Operating Income	-46	-45	-55	-63	-32	-25	3	-12	-14	0
EBITDA	-45	-44	-51	-60	-20	-23	5	-10	-13	0
Interest Expense	5	4	2	4	3	1	2	2	2	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-49	-48	-53	-64	-33	-25	3	-12	-15	-1
Income Tax Expense	-2	0	-	-	0	-	-	-	-	-
Net Income	-49	-48	-53	-64	-33	-25	3	-12	-15	-1
Net Profit Margin	-7087.75%	-4282.92%	-3244.02%	-3703.49%	-127.16%	-2004.36%	11.27%	-90.04%	-282.72%	-4.94%

Lexicon Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	83	90	63	322	23	0	0	1	31	49
Gross Profit	-80	88	60	318	22	-54	-52	-57	30	49
Operating Income	-137	-136	-103	141	-47	-87	-100	-171	-197	-48
EBITDA	-125	-125	-96	148	-41	-86	-100	-169	-184	-41
Interest Expense	6	6	20	20	14	0	2	13	15	8
Depreciation	-	3	3	3	2	0	0	0	0	0
Income Before Tax	-141	-141	-120	124	-58	-87	-101	-177	-200	-50
Income Tax Expense	4	-12	3	-6	11	0	1	0	-200	-
Net Income	-141	-129	-120	130	-58	-87	-101	-177	-200	-50
Net Profit Margin	-169.71%	-142.86%	-190.71%	40.40%	-244.11%	-29448.99%	-73341.01%	-14710.88%	-644.78%	-101.08%

Lexicon Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-48	-53	-64	-33	-25	3	-12	-15	-1
Operating Cash Flow	-55	-48	-53	-21	-43	16	-23	-17	-14
Investing Cash Flow	-110	-12	53	53	40	15	52	4	-70
Financing Cash Flow	239	0	0	0	0	-45	-	-2	88
Change in Cash	74	-60	-1	32	-3	-12	28	-15	3

Lexicon Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-129	-120	130	-58	-87	-101	-177	-200	-50
Operating Cash Flow	-185	-148	113	-142	-87	-88	-161	-178	-67
Investing Cash Flow	50	169	-155	380	2	-71	-49	-15	113
Financing Cash Flow	149	-2	-2	-147	22	142	187	238	-48
Change in Cash	15	18	-44	90	-62	-17	-23	44	-3

Global Institutional Holdings in Lexicon Pharmaceuticals Inc.

Funds	Holdings
Artal Group S A	34.83%
HRT FINANCIAL LLC	0.13%
Sessa Capital IM LP	0.83%
Siren, L.L.C.	9.97%
Susquehanna International Group, LLP	0.48%

See all

Insights on Lexicon Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, LXRX stock has moved up by 45.0%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 5.49M → 21.10M (in $), with an average increase of 74.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -15.53M → -1.04M (in $), with an average increase of 1389.0% per quarter
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 619.9% return, outperforming this stock by 615.4%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 418.1% return, outperforming this stock by 252.3%

About Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Organisation	Lexicon Pharmaceuticals Inc.
Headquarters	2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381
Industry	Biotechnology
CEO	Dr. Michael S. Exton Ph.D.
E-voting on shares	Click here to vote

Key Management of Lexicon Pharmaceuticals Inc.

Name	Title
Ms. Wendy E. McDermott	Senior Vice President of Human Resources
Dr. Suma Gopinathan M.S., Ph.D.	Senior Vice President of Discovery
Ms. Rachel Yap Martens	Senior VP of Partnerships & Corporate Strategy
Ms. Kristen L. Alexander	Vice President of Finance & Accounting
Ms. Lisa M. DeFrancesco	Senior Vice President of Investor Relations & Corporate Communications
Dr. Michael S. Exton Ph.D.	CEO & Director
Mr. Scott M. Coiante	Senior VP & CFO
Mr. Brian T. Crum	Senior VP, General Counsel & Secretary
Dr. Craig B. Granowitz M.D., Ph.D.	Senior VP & Chief Medical Officer

FAQs

What is Lexicon Pharmaceuticals Inc. share price today?

Lexicon Pharmaceuticals Inc. share price today is $2.32 as on July 7, 2026 at 8:46 am IST at the close of the market. Lexicon Pharmaceuticals Inc. share today touched a day high of $2.42 and a low of $2.30.

What is the 52 week high and 52 week low for Lexicon Pharmaceuticals Inc. share?

Lexicon Pharmaceuticals Inc. share touched a 52 week high of $2.68 on June 30, 2026 and a 52 week low of $0.84 on July 7, 2025. Lexicon Pharmaceuticals Inc. stock price today i.e. July 7, 2026 at 8:46 am IST is closed at $2.32,which is 13.43% down from its 52 week high and 177.41% up from its 52 week low.

What is Lexicon Pharmaceuticals Inc.'s market capitalisation today?

Lexicon Pharmaceuticals Inc. market capitalisation is $0.00T as on July 7, 2026 at 8:46 am IST.

How to invest in Lexicon Pharmaceuticals Inc. Stock (LXRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lexicon Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lexicon Pharmaceuticals Inc. Shares that will get you 0.6466 shares as per Lexicon Pharmaceuticals Inc. share price of $2.32 per share as on July 7, 2026 at 8:46 am IST.

What is the minimum amount required to buy Lexicon Pharmaceuticals Inc. Stock (LXRX) from India?

Indian investors can start investing in Lexicon Pharmaceuticals Inc. (LXRX) shares with as little as ₹95.395 or $1 (as of July 7, 2026 at 3:46 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.95 in Lexicon Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on July 7, 2026 at 3:46 pm IST). Based on Lexicon Pharmaceuticals Inc. share’s latest price of $2.32 as on July 7, 2026 at 8:46 am IST, you will get 4.3103 shares of Lexicon Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Lexicon Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Lexicon Pharmaceuticals Inc. stock has given -40.36% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?